» Articles » PMID: 31921609

Enhances Pentobarbital-induced Sleeping Behaviors

Overview
Date 2020 Jan 11
PMID 31921609
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Sleep disorders are among the most common psychiatric and medical conditions. In the present study, the hypnotic effect of was studied in mice

Materials And Methods: The hydro-alcoholic extract (HAE) of and three fractions of it, namely water fraction (WF), ethyl acetate fraction (EAF), and -hexane fraction (NHF), were intraperitoneally (ip) administrated to mice 30 min before injection of sodium pentobarbital (30 mg/kg, ip). Then, 30 min after administration of HAE, motor coordination (rota-rod test) was evaluated. Besides, LD of HAE was determined and the cytotoxicity of HAE was evaluated in PC12 cells using the MTT assay.

Results: HAE 50-200 mg/kg increased the sleeping time. EAF was the only fraction which could prolong the sleep duration and decrease sleep latency. The LD50 value was 4.8 g/kg. The extract induced no cytotoxic effects in PC12 cell line.

Conclusion: The results suggested that potentiates pentobarbital hypnosis without causing toxic effects. Probably, its effects are mediated by the components present in EAF of this plant.

Citing Articles

Exploring the Phytochemistry, Signaling Pathways, and Mechanisms of Action of (L.) Sch.Bip.: A Comprehensive Literature Review.

Kashkooe A, Jalali A, Zarshenas M, Hamedi A Biomedicines. 2024; 12(10).

PMID: 39457613 PMC: 11505096. DOI: 10.3390/biomedicines12102297.


Safety Aspects of Herb Interactions: Current Understanding and Future Prospects.

Hazra S, Singh P Curr Drug Metab. 2024; 25(1):28-53.

PMID: 38482621 DOI: 10.2174/0113892002289753240305062601.


Edible Herbal Medicines as an Alternative to Common Medication for Sleep Disorders: A Review Article.

Hosseini A, Mobasheri L, Rakhshandeh H, Baradaran Rahimi V, Najafi Z, Askari V Curr Neuropharmacol. 2023; 22(7):1205-1232.

PMID: 37345244 PMC: 10964091. DOI: 10.2174/1570159X21666230621143944.


Neuropharmacological Effects in Animal Models and HPLC-Phytochemical Profiling of (L.) Kunth Bark Extracts.

de la Cabeza Fernandez M, Sanchez M, Caceres A, Iglesias I, Gomez-Serranillos M Molecules. 2023; 28(2).

PMID: 36677821 PMC: 9867209. DOI: 10.3390/molecules28020764.


Preliminary evaluation of the efficacy and safety of brimonidine for general anesthesia.

Bin C, Xiaohui W, Mengrou S, Xin L, Ting Z, Ping G BMC Anesthesiol. 2021; 21(1):305.

PMID: 34861822 PMC: 8641169. DOI: 10.1186/s12871-021-01516-1.


References
1.
Long C, Sauleau P, David B, Lavaud C, Cassabois V, Ausseil F . Bioactive flavonoids of Tanacetum parthenium revisited. Phytochemistry. 2003; 64(2):567-9. DOI: 10.1016/s0031-9422(03)00208-5. View

2.
Ishisaka A, Ichikawa S, Sakakibara H, Piskula M, Nakamura T, Kato Y . Accumulation of orally administered quercetin in brain tissue and its antioxidative effects in rats. Free Radic Biol Med. 2011; 51(7):1329-36. DOI: 10.1016/j.freeradbiomed.2011.06.017. View

3.
Kambe D, Kotani M, Yoshimoto M, Kaku S, Chaki S, Honda K . Effects of quercetin on the sleep-wake cycle in rats: involvement of gamma-aminobutyric acid receptor type A in regulation of rapid eye movement sleep. Brain Res. 2010; 1330:83-8. DOI: 10.1016/j.brainres.2010.03.033. View

4.
Pareek A, Suthar M, Rathore G, Bansal V . Feverfew (Tanacetum parthenium L.): A systematic review. Pharmacogn Rev. 2011; 5(9):103-10. PMC: 3210009. DOI: 10.4103/0973-7847.79105. View

5.
Riemann D, Nissen C, Palagini L, Otte A, Perlis M, Spiegelhalder K . The neurobiology, investigation, and treatment of chronic insomnia. Lancet Neurol. 2015; 14(5):547-58. DOI: 10.1016/S1474-4422(15)00021-6. View